ArticleIJID regions2026
Drug resistance profile and species diversity in tuberculosis mycobacteria isolated from patients with presumptive tuberculosis in Brazzaville, Republic of Congo.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Speciation of tuberculosis (TB) causative organisms and drug sensitivity testing are important for TB management in high-TB burden countries, such as the Republic of Congo. This study determined the species diversity of Methods: A cross-sectional study involving 92 naïve patients with presumed pulmonary TB hospitalized at the Makelekele Hospital between October 2018 and October 2019. Liquid culture by the MGIT 960 system (Becton Dickinson) was applied for mycobacteria identification. Differentiation of MTBC organisms from non-TB mycobacteria was done using the BD MGIT TBc Identification Test. Species-level identification within the MTBC was performed using the Bruker HAIN Line Probe Assay MTBC. Drug susceptibility testing was performed using the indirect proportion method on the BACTEC MGIT 960 system. Results: Of the 92 pulmonary TB presumptive enrolled, 48 (52.17%) were culture-positive. Among those, seven of 48 (14.6%) were non-tuberculous mycobacteria and 41 of 48 (85.4%) were identified as MTBC isolates. The MTBC strains were 80% Conclusion: This finding highlights a predominance of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.